Evidence map›Paper›PMID 41703302›Full record

ArticleNature neuroscience2026

Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Jackson W Mace, Sachin P Gadani, Matthew D Smith, Danny Galleguillos, Bong Gu Kang, Milton Roy, Meilian Liu, Benjamin Summers, Thomas Garton, Marjan Gharagozloo and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.Neurology(R) neuroimmunology & neuroinflammation · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jackson W Mace *Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9555-4759
Sachin P Gadani *Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Matthew D SmithDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6614-569X
Danny GalleguillosDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6987-9322
Bong Gu KangThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Milton RoyThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Meilian LiuThe Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Benjamin SummersDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Thomas GartonDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9352-8530
Marjan GharagozlooDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2166-4012
Alexander J GillDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Carlos A PardoDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-4128-5335
Elias S SotirchosDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8812-1637
Valina L DawsonDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2915-3970
Ted M DawsonDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Peter A CalabresiDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. peter.calabresi@med.uvm.edu.ORCID http://orcid.org/0000-0002-7776-6472

Funding

The Role of KV1.3 in Effector T cellsR01NS041435 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI CALABRESI, PETER A · 2000 to 2025
$5.8M
MIF Nuclease actions in Synuclein DementiasR01AG085688 · NIA · JOHNS HOPKINS UNIVERSITY · PI VALINA L. DAWSON, Ted M. Dawson · 2024 to 2026
$2.4M
PARP and MIF Nuclease Actions in TauopathiesR01AG093848 · NIA · JOHNS HOPKINS UNIVERSITY · PI VALINA L. DAWSON, Ted M. Dawson · 2026 to 2026
$653k
Inhibition of MIF nuclease-mediated parthanatos prevents neuron and oligodendrocyte death in the context of multiple sclerosisF31NS132520 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Jackson Mace · 2024 to 2026
$132k
The role of dynamin-1 in the trafficking of GABA(B) receptorsR03NS065725 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2009 to 2011
$107k
National Multiple Sclerosis Society (National MS Society) FAN-2007-36944National Multiple Sclerosis Society (National MS Society) FAN-2106-37832National Multiple Sclerosis Society (National MS Society) TA-2104-37423National Multiple Sclerosis Society (National MS Society) TA-2407-43578NIA NIH HHS R01 AG085688NIA NIH HHS R01 AG093848NINDS NIH HHS F31 NS132520NINDS NIH HHS R01 NS041435NINDS NIH HHS R03 NS065725U.S. Department of Defense (United States Department of Defense) W81XWH2210819U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) F31NS132520U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS065725U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS041435
6 · The paper itself

Abstract

Central nervous system inflammation is implicated in neurodegeneration across several disorders, including multiple sclerosis (MS). While marked therapeutic progress has been made in preventing relapses in MS, primary neuroprotection in this disease remains elusive. This, in part, is due to an incomplete understanding of the molecular pathways involved in immune-mediated neuronal death. Here we show that parthanatos, a recently described caspase-independent and DNA damage-induced cell death program, contributes to neuron death in the experimental autoimmune encephalomyelitis (EAE) mouse model of autoimmune neuroinflammation. We reveal that DNA damage increases in neurons during EAE, and that neurons are progressively lost over the disease course. Neurons in affected areas display intracellular hallmarks of the parthanatos cascade. Genetic or pharmacologic blockade of the final step in parthanatos, genomic fragmentation by macrophage migration inhibitory factor (MIF) nuclease, reduces neuron loss and disease severity. Transcriptomic characterization of neurons with and without MIF nuclease activity reveals parthanatos-dependent differences in response to EAE. Together, this work establishes parthanatos as a key mechanism of neuron cell death during neuroinflammation.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsNeuroinflammatory DiseasesNeuronsParthanatosAnimalsCell DeathDNA DamageFemaleMiceMice, Inbred C57BLIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMif protein, mouse

Identifiers

PMID41703302
PMCPMC13061646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.